RE:Revenue for 2022, any guesses?Based off what I'm seeing I believe UK and Germany will deliver some decent sales (40+) this year. Key sale at a leading German hospital earlier this year, mentions that demos are 100% converting to sales, posts by Angio and Cardiologic on demos and attendance at conferences, VPT mentioning teams were booked for demos thru March (this was earlier in the year), and rumor of 7 studies in uk at seven sites to take place this summer (again rumor) as well as Duke study to kick off this summer I like our odds.